In the TCGA Breast dataset [22], SLC2A1 was overexpressed compared with that in the normal samples in intraductal cribriform breast adenocarcinoma (fold change = 2.172), in male breast carcinoma (fold change = 3.575), in invasive ductal breast carcinoma (fold change = 2.557) and in invasive breast carcinoma (fold change = 2.251). This evidence concerns the gene SLC2A1 and invasive breast carcinoma.